Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246445 (US9447114, 1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | 7.2 | n/a |
Hydra Biosciences, Inc. US Patent | Assay Description TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246446 (US9447114, 2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | 7.2 | n/a |
Hydra Biosciences, Inc. US Patent | Assay Description TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246466 (US9447114, 27) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | 7.2 | n/a |
Hydra Biosciences, Inc. US Patent | Assay Description TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246465 (US9447114, 26) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | 7.2 | n/a |
Hydra Biosciences, Inc. US Patent | Assay Description TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246463 (US9447114, 24) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.84 | n/a | n/a | n/a | n/a | 7.2 | n/a |
Hydra Biosciences, Inc. US Patent | Assay Description TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246465 (US9447114, 26) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.91 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246464 (US9447114, 25) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15.7 | n/a | n/a | n/a | n/a | 7.2 | n/a |
Hydra Biosciences, Inc. US Patent | Assay Description TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246453 (US9447114, 13) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <21 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246458 (US9447114, 18) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 27 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246449 (US9447114, 5) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <27 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246456 (US9447114, 16) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 27 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246462 (US9447114, 23) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 27 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246450 (US9447114, 6) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <27 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246457 (US9447114, 17) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246451 (US9447114, 7) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 34.9 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246448 (US9447114, 4) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246454 (US9447114, 14) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 82.2 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246455 (US9447114, 15) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 112 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246446 (US9447114, 2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 117 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246466 (US9447114, 27) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 134 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246464 (US9447114, 25) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 168 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246460 (US9447114, 21) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 194 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246459 (US9447114, 19) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 226 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246463 (US9447114, 24) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 242 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246447 (US9447114, 3) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 340 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246461 (US9447114, 22) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 369 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246445 (US9447114, 1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 584 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246452 (US9447114, 8) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Short transient receptor potential channel 5 (Homo sapiens (Human)) | BDBM246467 (US9447114, 28) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.33E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Hydra Biosciences, Inc. US Patent | Assay Description The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t... | US Patent US9447114 (2016) BindingDB Entry DOI: 10.7270/Q2ST7NRD | |||||||||||
More data for this Ligand-Target Pair |